J Wieczorek, MD
Geriatric Medicine · Johnstown, PANPI 1356393672
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $693 of the $884 with a category attached, or 78.3%. 11 manufacturers reported payments, led by Boston Scientific at 37.9% of the total. 2025 is the largest year on record at $565, more than ten times the $26 reported in 2022.
Across 26 payments — averaging $34.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$336
- AstraZeneca$162
- Novo Nordisk$88
- Lilly USA, LLC$61
- GSK$60
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$49
- plus $130 from 5 others
What the payments were for
- Travel & lodging$19222%
- Food & beverage$69378%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $336 |
| AstraZeneca | 3 | $162 |
| Novo Nordisk | 5 | $88 |
| Lilly USA, LLC | 3 | $61 |
| GSK | 3 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Pfizer | 2 | $44 |
| Exact Sciences | 2 | $34 |
| Eisai Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN FLX$192
- Watchman$144
- AIRSUPRA$125
How this compares
$884 in reported general payments places this provider in the 80th percentile of 217 geriatric medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 138 | $132,595 |
| OzempicSemaglutide | 33 | $39,964 |
| JardianceEmpagliflozin | 47 | $36,399 |
| XareltoRivaroxaban | 36 | $35,297 |
| JanuviaSitagliptin Phosphate | 19 | $22,580 |
| TradjentaLinagliptin | 22 | $18,924 |
| TrulicityDulaglutide | 17 | $17,595 |
| InvokanaCanagliflozin | 18 | $15,064 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $14,985 |
| Humalog Kwikpen U-100Insulin Lispro | 49 | $13,704 |
| Mesalamine | 11 | $12,719 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $11,407 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,907 |
| BrilintaTicagrelor | 12 | $10,478 |
| Atorvastatin Calcium | 674 | $9,496 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $44 | $132,595138 claims |
| Novo NordiskOzempic | $88 | $39,96433 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $60 | $25,89243 claims |
| Lilly USA, LLCTrulicity, Humalog | $61 | $20,86628 claims |
| AstraZenecaBrilinta | $162 | $10,47812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 217 geriatric medicine providers in Pennsylvania.
Other geriatric medicine in Johnstown
- Fredrick MunzerJohnstown$2K
- Richard StefanacciPhiladelphia$146K
- James LinErie$73K
- Adele TowersPittsburgh$29K
- Michele ZaworaPhiladelphia$21K
- Daniel HaimowitzLevittown$15K
- Robert PearlsteinPlymouth Meeting$15K
- Seth CarterErie$14K
- Moushumi KunduHanover$12K
- Jason KarlawishPhiladelphia$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.